Sulfasalazine - This is a recently added prescription medication to my "varying" lists of Lupus, Rheumatoid Arthritis, Sjogren's, and others list. I had not been on this one before the past about 6 weeks. My Rheumatologist, who is now a researcher and teacher; along with having his practice, suggested we try this after me having a long stent of biologic medications, that seem to cause me issues with infections, of which the last was double pneumonia. So, I am hoping and praying the Sulfasalazine does the trick. But, I have been on it along with the MTX and Plaquenil and now due to a Lupus flare, I am on the huge 14 day step down dose of Prednisone... and I am in a world of hurt today. I shall say weather, because we are expecting thunderstorms later this evening and tonight. But, we may be facing Orencia and giving it a try again. We tried it one time before, but for some reason we switched and went to another, so I don't think the Orencia got a fair chance to work. I will post information on it below this post for those who are interested.
Here is a list of a few of the Biologics out -
Simponi Aria -
This medication is used in combination with another drug (methotrexate) to treat a certain type of arthritis (rheumatoid arthritis). Golimumab belongs to a class of drugs known as TNF blockers. It works by blocking a protein (tumor necrosis factor - TNF) in your body's immune system that causes joint swelling and damage. Golimumab helps slow joint damage and reduce joint pain/swelling so you can move better. Simponi Aria is usually used as an infusion, where the medications is put into your body through and IV like many of the "stronger" Biologic Medications are.
Our latest venture in the realms of "new medications used to actually "fight" against the issues such as a ( Rutiuxan, Simppm]
also known as follow-on biologics are biologic medical products whose active drug substance is made by a living organism or derived from a living organism by means of recombinant DNA or controlled gene expression methods.
Biosimilars (or follow-on biologics) are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Biosimilars are also referred to as subsequent entry biologics (SEBs) in Canada. Reference to the innovator product is an integral component of the approval.